The Dark Side of “Smart Drugs”: Cognitive Enhancement vs. Clinical Concerns
Abstract The European Union Drugs Agency has emphasized the increasing difficulty in monitoring the drug market due to the emergence…
cognitive enhancers
Characterizing intergenic transcription at RNA polymerase II binding sites in normal and cancer tissues
Abstract Intergenic transcription in normal and cancerous tissues is pervasive but incompletely understood. To investigate this, we constructed an atlas…
Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs
Abstract Post-traumatic stress disorder (PTSD) is a chronic psychiatric disease resulting from the experience or witnessing of traumatic events. Persistent…
The Psychonauts’ World of Cognitive Enhancers
Abstract Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in…